Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now

BACKGROUND: Pancreatic cancer (PC) is a lethal disease, however current screening methods unable to achieve early diagnosis. Blood-based microRNAs (miRNAs) are promising molecular biomarkers for detecting PC. This meta-analysis summaries studies identifying serum- or plasma-based miRNAs dysregulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lunshou, Yao, Kunhou, Gan, Shibao, Suo, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392607/
https://www.ncbi.nlm.nih.gov/pubmed/30170450
http://dx.doi.org/10.1097/MD.0000000000012132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392607/
https://www.ncbi.nlm.nih.gov/pubmed/30170450
http://dx.doi.org/10.1097/MD.0000000000012132

Ejemplares similares